The global controlled release drug delivery market accounted for US$ 40.37 billion in 2020 and is estimated to be US$ 83.02 billion by 2030 and is anticipated to register a CAGR of 7.50%. Controlled release drug delivery system is used to release drug at a desired rate over a certain period of time which helps to maintain the therapeutic level in blood. For example, controlled release drug delivery system helps improve the efficacy ratio of the administered therapeutic. Uniform drug effect, less fluctuation in plasma drug levels, improved patient acceptance and compliance, and reduction in dosage frequency are some of the other benefits that a controlled release drug delivery system offers.
The report " Global Controlled Release Drug Delivery Market, By Technology (Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery, and Others (Micro-electromechanical Technology and Liposomes)), By Release Mechanism (Polymer Matrix Based Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, Feedback Regulated Drug Delivery Systems, Activation-modulated Drug Delivery Systems, and Chemically Activated), By Application (Metered Dose Inhalers, Injectable, Transdermal and Ocular Patches, Infusion Pumps, Oral Controlled-Drug Delivery Systems, and Drug Eluting Stents) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030”
Key Highlights:
- In 2021, Pfizer Inc. (NYSE: PFE) announced positive top-line results from the Phase 2b/3 ALLEGRO trial evaluating oral once-daily ritlecitinib in patients with alopecia areata, an autoimmune disease driven by an immune attack on the hair follicles that causes hair loss on the scalp and can also affect the face and body.
- In 2021, KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, today announced the U.S. commercial launch of AZSTARYS™, a once-daily product for the treatment of attention deficit hyperactivity disorder (ADHD) in patients age six years and older. Corium, Inc. (Corium), a portfolio company of Gurnet Point Capital (GPC), is leading the commercialization of AZSTARYS in the U.S.
Analyst View:
Advancements in drug delivery system which includes its mechanical strength, ability to give comfort for patient, and capability to achieve high drug loading are driving growth of the global controlled release drug delivery market. In addition, controlled release drug delivery have various advantages like reduction in drug accumulation, reduced drug toxicity, stabilized medical condition due to more uniform drug levels, etc., which is boosting the growth of the global market. However, potential disadvantages like possible toxicity or non-biocompatibility of the materials used are expected to hamper growth of the global market. In addition to this high cost of controlled release systems compared to traditional pharmaceutical formulations is expected to challenge growth of the global controlled release drug delivery market to certain extent.
Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Controlled Release Drug Delivery Market, By Technology (Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery, and Others (Micro-electromechanical Technology and Liposomes)), By Release Mechanism (Polymer Matrix Based Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, Feedback Regulated Drug Delivery Systems, Activation-modulated Drug Delivery Systems, and Chemically Activated), By Application (Metered Dose Inhalers, Injectable, Transdermal and Ocular Patches, Infusion Pumps, Oral Controlled-Drug Delivery Systems, and Drug Eluting Stents) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030”
To know the upcoming trends and insights prevalent in this market, click the link below:
https://www.prophecymarketinsights.com/market_insight/Global-Controlled-Release-Drug-Delivery-1037
Key Market Insights from the report:
The global controlled release drug delivery market accounted for US$ 40.37 billion in 2020 and is estimated to be US$ 83.02 billion by 2030 and is anticipated to register a CAGR of 7.50%. The Global controlled release drug delivery market is segmented based on technology, release mechanism, application, and region.
- By Technology, the market is segmented into wurster technique, coacervation, micro encapsulation, implants, transdermal, targeted delivery, and others.
- By Release Mechanism, the market is segmented into polymer matrix based systems, micro reservoir partition controlled drug delivery systems, feedback regulated drug delivery systems, activation-modulated drug delivery systems and chemically activated.
- By Application, the market is segmented into metered dose inhalers, injectable, transdermal and ocular patches, infusion pumps, oral controlled-drug delivery systems, and drug eluting stents.
- By Region, the Global Viral Clearance Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
To know more
Contact Us:
Sales
Prophecy Market Insights
Email- [email protected]
Global Controlled Release Drug Delivery Market Research Report, by Route of administration (Transdermal, Oral), Release Mechanism (Polymer-based, Micro reservoir Partition), Products (Metered Dose Inhalers), End User (Hospital)— Forecast till 2023Controlled release drug delivery is a method of doling out drugs in required doses to patients.
Market Research Future (MRFR) has compiled the topmost trends, opportunities, and growth drivers of the global controlled release drug delivery market report with forecasts for the period between 2017 and 2023.Controlled Release Drug Delivery Market OutlookThe Global Advanced Controlled Release Drug Delivery Market is set to achieve a jump in valuation from USD 31.96 billion in 2017 to USD 70.15 billion by 2023, according to MRFR.
Key factors driving market growth include rising cases of patient deaths due to overdose, health problems from high doses, and rising R efforts in the healthcare industry.
Advantages pertaining to the technology such as reduction of toxin accumulation, acclimatization of patients to the dose rate, and stability of the medical condition can influence the controlled drug delivery market demand.Low awareness of the technology and high costs per dose can negatively impact the market growth trajectory.Controlled Release Drug Delivery Market Competitive LandscapeAllergan, SKY Pharmaceuticals Pvt.
Ltd., Alza Corporation (Johnson & Johnson), Novartis, Depomed, Inc. (US), AstraZeneca, Collegium Pharmaceutical, GlaxoSmithKline, Pfizer Inc., Corium International Inc., Coating Place, Inc., Biogen, and others are key market participants.Controlled Release Drug Delivery Market SegmentationThe global controlled release drug delivery market is segmented on the basis of route of administration, release mechanism, products, and end users.By route of administration the market is segmented into nasal, oral, ocular, topical, implantable, and injectable.
The injectable is sub-segmented into targeted delivery, transmucosal, and transdermal.On the basis of the release mechanism, the market is segmented into activation modulated drug delivery systems, polymer-based drug delivery systems, feedback-regulated drug delivery systems, micro-reservoir partition-controlled drug delivery systems, and chemically activated controlled drug delivery systems.
Global Controlled Release Drug Delivery Market is expected to reach USD 90.18 billion by 2025.
The controlled release drug delivery market is estimated to grow at a significant CAGR of 13.8% over the future period as the scope and its applications are rising enormously across the globe.
Controlled release drug delivery market is segmented based on technology, mechanism, application, and region.Download Free Sample Report @ https://www.millioninsights.com/industry-reports/controlled-release-drug-delivery-market/request-sampleHighly enhanced technology used includes Targeted Delivery, Wurster Technique, Transdermal, Coacervation, Implants, Micro Encapsulation, and others that could be explored in controlled release drug delivery market in the future period.
Targeted delivery sector accounted for the largest market share of controlled release drug delivery and is estimated to lead the overall market in the coming years.
However, micro encapsulation sector is estimated to grow at fastest pace in the coming years.Chemically Activated, Polymer Matrix Based Systems, Activation-modulated Drug Delivery Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, and Feedback Regulated Drug Delivery Systems are the release mechanisms that could be explored in controlled release drug delivery market in the forecast period.
Chemically activated sector accounted for the largest market share of controlled release drug delivery and is estimated to lead the overall market in the coming years.
Global Controlled Release Drug Delivery Market is expected to reach USD 90.18 billion by 2025.
The controlled release drug delivery market is estimated to grow at a significant CAGR of 13.8% over the future period as the scope and its applications are rising enormously across the globe.
Controlled release drug delivery market is segmented based on technology, mechanism, application, and region.Highly enhanced technology used includes Targeted Delivery, Wurster Technique, Transdermal, Coacervation, Implants, Micro Encapsulation, and others that could be explored in controlled release drug delivery market in the future period.
Targeted delivery sector accounted for the largest market share of controlled release drug delivery and is estimated to lead the overall market in the coming years.
However, micro encapsulation sector is estimated to grow at fastest pace in the coming years.Chemically Activated, Polymer Matrix Based Systems, Activation-modulated Drug Delivery Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, and Feedback Regulated Drug Delivery Systems are the release mechanisms that could be explored in controlled release drug delivery market in the forecast period.
Chemically activated sector accounted for the largest market share of controlled release drug delivery and is estimated to lead the overall market in the coming years.
